SYNLOGIC, INC. Increase (Decrease) in Accounts Payable
SYNLOGIC, INC. (SYBX) reported Increase (Decrease) in Accounts Payable of -$314.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2017-08-04
- SYNLOGIC, INC. increase (decrease) in accounts payable for the quarter ending 2017-06-30 was -$324.00K.
- SYNLOGIC, INC. increase (decrease) in accounts payable for the quarter ending 2017-03-31 was $10.00K.
- SYNLOGIC, INC. increase (decrease) in accounts payable for the quarter ending 2016-12-31 was -$381.00K, a 124.97% decline year-over-year.
- SYNLOGIC, INC. increase (decrease) in accounts payable for the quarter ending 2016-09-30 was -$299.00K, a 131.02% decline year-over-year.
- SYNLOGIC, INC. increase (decrease) in accounts payable for fiscal 2016 was -$3.26M, a 215.91% decline from fiscal 2015.
- SYNLOGIC, INC. increase (decrease) in accounts payable for fiscal 2015 was $2.82M, a 1389.95% increase from fiscal 2014.
- SYNLOGIC, INC. increase (decrease) in accounts payable for fiscal 2014 was $189.00K.
- SYNLOGIC, INC. increase (decrease) in accounts payable for fiscal 2013 was -$132.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$314.00K 10-Q · filed 2017-08-04 | -$695.00K derived: sum of 3 quarters · filed 2017-08-04 | -$994.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2017-03-31 | $10.00K 10-Q · filed 2017-05-09 | -$371.00K derived: sum of 2 quarters · filed 2017-05-09 | -$670.00K derived: sum of 3 quarters · filed 2017-05-09 | -$806.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-12-31 | -$381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$680.00K derived: sum of 2 quarters · filed 2017-03-15 | -$816.00K derived: sum of 3 quarters · filed 2017-08-04 | -$3.26M 10-K · filed 2017-03-15 |
| 2016-09-30 | -$299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$435.00K derived: sum of 2 quarters · filed 2017-08-04 | -$2.88M 10-Q · filed 2016-11-10 | -$1.36M derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-06-30 | -$136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$2.58M 10-Q · filed 2017-08-04 | -$1.06M derived: sum of 3 quarters · filed 2017-08-04 | -$94.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | -$2.45M 10-Q · filed 2017-05-09 | -$922.00K derived: sum of 2 quarters · filed 2017-05-09 | $42.00K derived: sum of 3 quarters · filed 2017-05-09 | $169.00K derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $2.49M derived: sum of 2 quarters · filed 2017-03-15 | $2.62M derived: sum of 3 quarters · filed 2017-03-15 | $2.82M 10-K · filed 2017-03-15 |
| 2015-09-30 | $964.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.09M derived: sum of 2 quarters · filed 2016-11-10 | $1.29M 10-Q · filed 2016-11-10 | $1.40M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $326.00K 10-Q · filed 2016-08-15 | $440.00K derived: sum of 3 quarters · filed 2017-03-15 | |
| 2015-03-31 | $199.00K 10-Q · filed 2016-05-12 | $313.00K derived: sum of 2 quarters · filed 2017-03-15 | ||
| 2014-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $189.00K 10-K · filed 2017-03-15 | ||
| 2014-09-30 | $75.00K 10-Q · filed 2015-11-13 | |||
| 2013-12-31 | -$132.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |